Health

Innovative region: Japan

Sector report: consumer

The small molecule drug developer, co-founded by a UCLA associate professor, has completed its series B round.

SK Hynix, Marvell and M12 helped data centre technology producer D-Matrix pull in $44m while health insurance provider SafetyWing raised $35m from investors including Digital Garage and CreditEase.

Bristol Myers Squibb was among the investors in a series B round announced alongside a collaboration with the small molecule drug developer.

Accenture, Workday and Bank of America helped VR training technology developer Strivr expand its latest round to $65m while Consensys backed a $50m round for blockchain analytics provider Flipside Crypto.

The gene-editing technology developer received further support from SoftBank Vision Fund 2 to advance its genomics drug discovery platform.

Citi Ventures, Salesforce Ventures and Telstra Ventures all invested in blockchain infrastructure provider Blockdaemon's series D round while GV backed cybersecurity software provider Obsidian's $90m series C.

Takeda and Bristol Myers Squibb were among the investors that helped the cellular medicine developer close its series B round.

Several corporate venture investors participated in a round which took the crypto IoT network developer's valuation to $1.2bn. The round and the company are part of the larger crypto tech space, which has been attracting much interest and capital in most recent times.

BMW and Ralph Lauren contributed to an $85m round for sustainable materials provider Natural Fiber Welding while Credit Saison invested $80m in virtual credit card service Julo.